Veterinary In Vitro Fertilization Market Report Scope & Overview:

The Veterinary In Vitro Fertilization Market was valued at USD 1.75 Billion in 2025 and is expected to reach USD 3.32 Billion by 2035, growing at a CAGR of 6.60% from 2026-2035.

The veterinary in vitro fertilization market will gain momentum owing to the increasing need for genetically superior livestock, the growing adoption of advanced reproductive technologies, and the rising involvement of governments in breeding and conservation of animals. Breeders are adopting Ovum Pick-Up and In Vitro Embryo Production methods to leverage the genetic superiority of donor animals for better performance in terms of milk production and meat production. Affordable region-specific IVF consumables have increased the reach of the technology beyond expensive breeding facilities. The application of the technology in conservation of wildlife opens up new prospects for research and investment.

In January 2024, the BioRescue consortium achieved the first successful embryo transfer in southern white rhinos, advancing conservation efforts for the northern white rhino. Using IVF and preserved genetic material, researchers demonstrated that embryo transfer is feasible in large mammals, highlighting veterinary IVF’s expanding role in wildlife preservation and species recovery.

Veterinary In Vitro Fertilization Market Trends

• Ovum Pick-Up combined with In Vitro Embryo Production is increasingly replacing traditional in vivo breeding methods in elite cattle programs.

• Indigenous, cost-reduced IVF media developed in emerging markets are lowering per-embryo costs and expanding accessibility for smallholder farmers.

• AI-based decision support tools for embryo grading and time-lapse incubation are improving embryologist workflow and selection accuracy.

• Portable, on-farm reproductive imaging and ultrasound scanners are enabling real-time diagnostics and ovum pick-up procedures outside the laboratory.

• Expansion of IVF applications beyond livestock and companion animals into wildlife conservation is broadening the market's long-term scope.

• Consolidation among assisted reproductive technology equipment and consumables suppliers is creating larger, more integrated global vendors.

U.S. Veterinary In Vitro Fertilization Market Outlook

The U.S. Veterinary In Vitro Fertilization Market was valued at USD 0.44 Billion in 2025 and is expected to reach USD 0.78 Billion by 2035, growing at a CAGR of 5.89% from 2026-2035.

The U.S. Veterinary In Vitro Fertilization Industry operates under the influence of several driving forces such as wide prevalence of OPU and IVP procedures in cattle and horses breeding, extensive availability of veterinary fertility clinics and embryology laboratories, and advanced reproductive technology manufacturers headquartered in the US. The country is at the cutting edge of artificial intelligence applications in embryo evaluation, mobile reproductive imaging, and automation of laboratory processes, while research organizations such as University of California Davis conduct pioneering studies in equine IVF through frozen sperm. An increasing tendency to introduce on-farm IVF and cryopreservation is also improving access to these technologies for cattle and equine breeders.

In December 2024, Astorg completed the acquisition of Hamilton Thorne and Cook Medical’s Reproductive Health division, creating a combined global assisted reproductive technology company. Operating under a new brand in 2025, the merger expanded its U.S. installed base for embryology instruments and consumables, highlighting continued consolidation across the reproductive technology supply chain.

Veterinary In Vitro Fertilization Market Segment Analysis

• By Product, the Reagents/Consumables segment dominated the Veterinary In Vitro Fertilization Market with approximately 45.10% share in 2025, and is also the fastest growing with a CAGR of approximately 9.15%.

• By Animal, the Bovine segment dominated the Veterinary In Vitro Fertilization Market with approximately 42.80% share in 2025, while the Other Animals segment is the fastest growing with a CAGR of approximately 9.40%.

• By Technique, the Embryo Transfer segment dominated the Veterinary In Vitro Fertilization Market with approximately 44.50% share in 2025, while the Ovum Pickup segment is the fastest growing with a CAGR of approximately 8.90%.

• By End Use, the Veterinary Fertility Clinics segment dominated the Veterinary In Vitro Fertilization Market with approximately 44.20% share in 2025, while the Veterinary Hospitals segment is the fastest growing with a CAGR of approximately 9.25%.

By Product, Reagents/Consumables Dominates and Is Also the Fastest Growing

Reagents and consumables are crucial throughout the process of IVF, from oocyte manipulation through embryo culture, cryopreservation, and embryo transfer. Regardless of which specific techniques and which species a lab supports, this particular segment is extremely important. The growing popularity of OPU and embryo production in bovine, equine, and exotic species has created a strong need for good culture media, special pipettes, and cryopreservation reagents. It is therefore the biggest contributor to the company’s revenues.

This segment is also expanding fastest as regionally developed, lower-cost IVF media reduce dependency on imported alternatives and broaden accessibility for smaller breeding operations that previously found consumable costs prohibitive. Recurring, per-cycle consumption of media, pipettes, and cryoprotectants ties this segment's growth directly to the expanding volume of IVF procedures performed globally, giving it a structurally faster growth trajectory than durable instruments or one-time service fees.

By Animal, Bovine Dominates and Other Animals Grows Fastest

The bovine segment leads the market, reflecting the high economic value of cattle and the widespread use of embryo transfer and in vitro embryo production to enhance milk yield, meat quality, and genetic merit across both dairy and beef operations. Elite donor cow programs in major cattle-producing countries routinely rely on IVF-derived embryos to multiply superior genetics far faster than natural breeding would allow, sustaining this segment's leading revenue contribution.

The other animals group, which includes horses, pigs, small ruminants, companion animals, and even exotic and endangered animals, is increasing at the highest rate due to breeding horses that are economically valuable, conservation-oriented research on reproduction, and the use of fertility treatment on companion animals. This area will benefit greatly from the new developments in stem cells-derived gametes and species-specific IVF methods.

By Technique, Embryo Transfer Dominates and Ovum Pickup Grows Fastest

Embryo transfer remains the most commercially established technique, valued for its high success rates, repeatability, and ability to multiply genetically superior embryos from elite donor animals into surrogate recipients. Breeding programs across major cattle-producing regions routinely use embryo transfer to produce multiple offspring from a single prize animal, making it the most revenue-generating IVF technique in both dairy and beef operations.

Ovum Pickup is emerging very fast as a minimally invasive technique to harvest a number of top quality eggs from superior females through an easy process without undergoing any surgery. It helps in achieving repetitive collection cycles that aid in rapid genetic breeding programs. The increasing utilization of the procedure in dairy and beef cattle breeding as well as horse and exotic animals breeding programs is helping its growth.

By End Use, Veterinary Fertility Clinics Dominate and Veterinary Hospitals Grow Fastest

Veterinary fertility clinics currently lead the market in demand due to their specialist nature concerning reproductive services such as embryo transfer, genetic diagnosis, and assisted reproduction for valuable livestock and companion animals. Their highly specialized approach to the treatment, personalized client interactions, and adoption of novel IVF techniques contribute towards successful treatments and ensure that they retain their dominant position in the market.

The veterinary hospitals are currently growing at the fastest pace since they incorporate techniques like embryo transfer, oocyte collection, and freezing within their practice while providing 24-hour care and surgery facilities. The cooperation of hospitals with biotech companies and research organizations is ensuring that IVF program is commercialized in veterinary hospitals.

Regional Analysis

North America Veterinary In Vitro Fertilization Market Insights

North America accounted for approximately 30.80% of the global Veterinary In Vitro Fertilization Market in 2025, the largest share of any region, supported by technological innovation, expanding breeding programs, and increasing demand for genetic enhancement in livestock. The United States drives the substantial majority of regional demand, leading in AI-assisted embryo assessment, portable reproductive imaging, and laboratory automation across its dense network of fertility clinics and embryology laboratories.

Canada continues to move ahead with rapidity through strategic partnership, and one such example is the partnership between Trans Ova Genetics and Evolygen in September 2025 aimed at setting up an IVF lab in Quebec. This represents a big stride towards localized production of embryos as well as development of the livestock genetics industry in Canada. There is a gradual shift to on-farm IVF services and cryopreservation within the region.

Europe Veterinary In Vitro Fertilization Market Insights

Europe can be considered a major regional market where growth will be fueled by the use of innovative assisted reproduction technologies such as portable on-farm scanners, species-specific methods, and automation in the laboratory that increase productivity and facilitate ovum pick-up procedures in the field. Strategic consolidation between equipment and consumable producers specializing in reproductive technology is creating larger consolidated players that have a wider presence and R&D capabilities throughout Europe.

Germany has the largest revenue share in Europe due to significant investments in animal biotechnology and reproductive science. This is illustrated by the example of Leibniz Institute for Zoo and Wildlife Research, which has developed pioneering techniques of in vitro fertilization used for the protection of wildlife. UK also experiences significant growth because of the development of IVF and embryo transfer in equine breeding centers aimed at solving fertility problems of valuable horses.

Asia Pacific Veterinary In Vitro Fertilization Market Insights

Asia Pacific is the fastest-growing regional market, projected to expand at a CAGR of approximately 9.60% between 2026 and 2035, driven by increased government-backed breeding programs, technological advancements, and rising demand for high-yield livestock across China, Australia, and South Korea. China represents a leading national market within the region, supported by expanding dairy operations and government initiatives for superior cattle breeding.

Australia's livestock sector is rapidly integrating embryo transfer and IVF to enhance beef and dairy genetics, while South Korean research institutions are investing in reproductive biotechnology to improve animal fertility and conserve endangered species. Japan is advancing through innovations in reproductive and stem cell technologies, exemplified by Osaka Metropolitan University's creation of feline induced pluripotent stem cells, extending IVF applications beyond livestock into companion animal fertility and disease research.

MEA & Latin America Veterinary In Vitro Fertilization Market Insights

The Middle East and Africa market is a two-track path, where Gulf countries focus on high-quality animals like camels and performance horses with the help of IVF, embryo transfer, and cloning to preserve elite lines and clinics in Saudi Arabia and the UAE specialize in embryo transfer. South Africa is known for its embryo-based reproductive services, including the presence of large providers of in vitro embryo production and cryopreservation for export purposes and in wildlife conservation, as it is the case in the rhino program BioRescue of Kenya.

Brazil is the leader among Latin American countries in terms of its embryological reproductive services market with a demand for genetic improvement of beef cattle via embryo transfer and in vitro embryo production and driven by large-scale operations applying innovative technologies to meet export requirements. Argentina is currently constructing its infrastructure, building new laboratories and cryopreservation facilities, while smaller countries, such as Mexico and Peru, are developing new IVF-related services among mid-size livestock farms.

Market Dynamics

Growth Drivers: Genetic Improvement Demand and Reproductive Technology Advancement

The growth of the Veterinary In-Vitro Fertilization Market is being fueled by the increasing need for genetically superior animals and consistent development in the technology of reproduction that can allow breeders to reproduce the genetically superior animals much faster than conventional methods. Ovum pick-up and in-vitro production of embryos are becoming increasingly common as compared to conventional methods, as they increase the efficiency of reproduction in cattle, equine, and small ruminants.

Animal breeding and conservation activities supported by the government and availability of cheaper IVF media that has been made regionally will increase the application of assisted reproductive technologies from high-end breeding facilities. In-vitro fertilization for wildlife conservation activities will increase investment and research in veterinary reproduction.

Restraints: High Cost of Veterinary IVF Services

The high cost associated with veterinary IVF procedures continues to act as a key constraint on market growth, limiting adoption primarily to premium and genetically valuable breeding programs. Establishing and operating IVF facilities requires significant capital investment in specialized laboratory infrastructure, advanced imaging systems, micromanipulation equipment, cryopreservation technologies, and highly skilled embryologists, all of which substantially increase procedural expenses.

In large animals such as cattle and horses, IVF-related expenditures are considerably higher due to additional requirements for animal handling, transportation, donor-recipient synchronization, and stringent biosecurity protocols, with equine IVF procedures capable of exceeding several thousand dollars per breeding attempt depending on pedigree value. As a result, veterinary IVF remains economically feasible largely for elite breeding operations, restricting broader adoption among small- and medium-scale breeders despite ongoing technological advancements.

Opportunities: Wildlife Conservation and Affordable Regional IVF Media

As IVF is increasingly applied from livestock and companion animals to wildlife conservation, it represents the emergence of a promising new frontier. Success stories of novel IVF embryo transfer procedures in critically endangered animal populations reflect such potential and show that there will be increased focus on investments, developments, and cross-cutting research on veterinary reproductive technologies. IVF will become an increasingly important tool in efforts at species survival and conservation.

In addition, the development of cost-effective native IVF media and accessories is opening up the veterinary IVF market to small-scale farmers in developing countries. With continued consolidation among assisted reproductive technology providers and greater integration of AI-based embryo evaluation techniques, along with advanced equipment, the suppliers see a clear roadmap for expanding their market share in what becomes more and more of a technological domain.

Recent Developments:

• 2025: Phase Holographic Imaging expanded into veterinary IVF, applying quantitative phase imaging and live-cell analysis to enable real-time monitoring of embryo and cell development, supporting greater precision in veterinary reproductive procedures.

• 2025: IMV Technologies introduced ImaGo L/C and ImaGo Flex fertility scanners, featuring portability, durability, color-flow Doppler, and species-specific settings to improve early pregnancy detection and on-farm veterinary reproductive diagnostics.

• 2024: Indian Immunologicals Limited and the National Dairy Development Board launched Shashthi, indigenous IVF media for livestock embryo transfer, reducing reliance on imports and improving affordability for Indian farmers.

• 2023: Hamilton Thorne acquired Gynetics Medical Products N.V., strengthening its assisted reproductive technology consumables portfolio while expanding European distribution capabilities and reinforcing its presence across the reproductive healthcare market.

• 2023: Esco Medical selected Fairtility’s CHLOE EQ AI decision-support tool for MIRI time-lapse incubators, aiming to support embryologists, improve decision-making accuracy, and streamline communication across IVF clinic teams.

Veterinary In Vitro Fertilization Market Key Players

• Zoetis Services LLC

• Genus PLC

• IMV Technologies Group

• Hamilton Thorne, Inc.

• Esco Medical

• Minitube GmbH

• Eppendorf SE

• Charles River Laboratories, Inc.

• Vitrolife AB

• SEMEX

• CRV Holding B.V.

• Select Sires Inc.

• Vytelle, LLC

• Bovine Elite LLC

• Swine Genetics International, Ltd.

• Kruuse

• Agetech Inc.

• Jorgensen Laboratories, Inc.

• Equine Fertility Centre

• Neogen Corporation

Veterinary In Vitro Fertilization Market Report Scope: